ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Marginal Zone B Cells Support Donor-Specific Alloantibody Responses to Heart Allografts

V. Gorbacheva, R. Fan, W. Baldwin, R. Fairchild, A. Valujskikh

Inflammation and Immunity, Cleveland Clinic, Cleveland, OH

Meeting: 2021 American Transplant Congress

Abstract number: 210

Keywords: IgG, MHC class I, MHC class II, Mice

Topic: Basic Science » B-cell / Antibody /Autoimmunity

Session Information

Session Name: B cell/Antibody and Histocompatibility

Session Type: Rapid Fire Oral Abstract

Date: Monday, June 7, 2021

Session Time: 4:30pm-5:30pm

 Presentation Time: 4:35pm-4:40pm

Location: Virtual

*Purpose: Production of high affinity isotype-switched donor specific alloantibodies (DSA) after transplantation is associated with germinal center formation by follicular (FO) B cells whereas the contribution of marginal zone (MZ) B cells is poorly understood. The goal of our study was to test the role of MZ B cells during alloimmune responses.

*Methods: To evaluate MZ B cell responses after transplantation, B6.Blimp-1 (H-2b) reporter mice were transplanted with BALB/c (H-2d) heart allografts. To test MZ B cells contribution to DSA production we treated B6.WT recipients of BALB/c heart allografts with anti-mCD20 18B12 IgG1 mAb that depletes >95% splenic FO but only 40-60% MZ B cells. Serum levels of class I and class II-reactive IgG and IgM DSA were determined by ELISA. We used S1PR1 signaling inhibitor FTY720 to prevent MZ B cells from returning to MZ area. To specifically test the role of MZ B cells in DSA production we used CD19CreNotch2fl/fl mice (ΔMZB) with defective development of MZ B cells as heart allograft recipients. In addition, sera collected fromΔMZB recipients and littermate controls on d.14 posttransplant was transferred to RAG1-/- recipients of BALB/c heart allograft

*Results: Blimp1+ MZ B cells in recipient spleen peaked at d. 7 and declined by d. 14 posttransplant, suggesting their differentiation into early antibody secreting cells. Preferential FO B cell depletion reduced serum IgG DSA levels only at later time points (d. 14 and d. 21), indicating that early IgG DSA are produced by residual MZ B cells. CD4 T cells depletion prior to transplantation showed that these early MZ B cell responses were critically dependent on T cell help. Treatment of heart allograft recipients with FTY720 displaced MZ B cells from spleen MZ area and markedly impaired both class I and class II DSA generation. IgG and IgM DSA generation in ΔMZB recipients was significantly impaired compared to control littermates, even though the priming of donor-reactive IFNγ producing T cells was similar between groups. Transfer of littermate but not ΔMZB sera collected on d.14 posttransplant to RAG1-/- BALB/c heart allograft recipients induced C4d complement deposition, indicating that MZ B cells are required to generate high levels of complement-activating DSA.

*Conclusions: Our findings are the first demonstration for the role of MZ B cells in humoral alloimmune responses following solid organ transplantation and identify MZ B cells as a potential therapeutic target for minimizing de novo DSA production and antibody-mediated rejection in transplant recipients.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Gorbacheva V, Fan R, Baldwin W, Fairchild R, Valujskikh A. Marginal Zone B Cells Support Donor-Specific Alloantibody Responses to Heart Allografts [abstract]. Am J Transplant. 2021; 21 (suppl 3). https://atcmeetingabstracts.com/abstract/marginal-zone-b-cells-support-donor-specific-alloantibody-responses-to-heart-allografts-2/. Accessed May 16, 2025.

« Back to 2021 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences